Exhibiting at Middle East Poultry Expo 2025

Vetoquinol Canada Inc., a subsidiary of the global veterinary pharmaceutical group Vetoquinol S.A., operates as a prominent manufacturer and exporter of veterinary health products in Canada. Headquartered in Lavaltrie, Quebec, the company plays a crucial role in the animal health ecosystem, offering a wide range of products for companion animals, livestock, and equine species, with a growing footprint in biosecurity solutions.

Company Background

Founded in 1933 in France, Vetoquinol has expanded into over 25 countries with a workforce exceeding 2,500 employees. Vetoquinol Canada contributes significantly to the group's North American operations, supporting both domestic and international veterinary needs. The Canadian branch integrates local manufacturing and research with the global group’s innovation strategies, ensuring products meet both local and international regulatory standards.

Core Business and Product Portfolio

Vetoquinol Canada specializes in veterinary pharmaceuticals and nutritional supplements. Its product range includes:

• Companion Animals:

  • Flexadin, Epakitin, Cothivet, Zylkene, Enisyl-F, Azodyl

• Farm Animals:

  • Bimectin, Lydaxx, Clavaseptin, Fertiline, NexHA, Farmafen

• Equine:

  • NexHA, Flexadin Advanced

• Biosecurity:

  • Biosolve Plus, Hyperox, Clinicide, Boot Hill, Fast Draw, Disvap Gold

These offerings support disease treatment, nutritional supplementation, joint health, reproductive support, and farm sanitation.

Specialization and Unique Value Proposition

Vetoquinol differentiates itself through:

• Dual Competency in pharmaceutical and nutraceutical development.
• Veterinary-Backed R&D with cross-functional collaborations.
• Holistic Health Focus including mental wellness and mobility products for companion animals.
• Dedicated Biosecurity Solutions supporting farm hygiene and pathogen control.

Financial Performance and Export Statistics

Globally, Vetoquinol reported revenue of €540 million in 2023, with North America contributing over 25% of group sales. Vetoquinol Canada is a key export hub, supplying markets across:

• North America (U.S., Mexico)
• Latin America (Brazil, Colombia)
• Asia-Pacific (India, Vietnam)

According to Volza and ImportYeti data, Vetoquinol Canada completed over 1,500 international shipments between 2020 and 2024. The most exported categories include injectables, antimicrobials, and nutritional supplements.

Target Market

• Veterinary clinics and hospitals
• Livestock and poultry farms
• Pet retail chains and distributors
• Agricultural cooperatives and integrators
• Biosecurity and sanitation services

Capabilities

• Local Manufacturing in Quebec with GMP-compliant facilities
• Cold Chain Logistics for temperature-sensitive medications
• Veterinary Education Programs and product training
• Multilingual Support across English, French, and Spanish markets

Certifications and Compliance

• Health Canada VHP Licensing
• Good Manufacturing Practices (GMP)
• ISO 9001:2015 Certification
• Compliance with CFIA, FDA, and EMA standards

Customer Testimonials

“Vetoquinol’s Flexadin range has drastically improved our canine patients’ mobility and comfort. It's our go-to supplement for osteoarthritis.”
— Veterinary Practitioner, Ontario

“Their biosecurity line, especially Hyperox and Biosolve Plus, is an integral part of our poultry hygiene protocol.”
— Farm Operations Manager, Manitoba

Achievements and Recognition

• Awarded Best Veterinary Supplement Brand 2023 by Canadian Vet Journal.
• Featured as a top 10 animal health exporter in Canada by AgriTech Insights.
• Successfully launched Lydaxx, a next-gen injectable antibiotic, in 12 countries.
• Expanded e-learning and certification platform for veterinary clients in 2022.